ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,437.10
0.41%
S&P ASX All Technology
3,874.70
1.23%
Brent Oil
78.575
-0.22%
US Dollar vs AUD
1.59616
-0.06%
Bitcoin
105,794.39
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ishares Nasdaq Biotechnology (0JGB) Share Price

Ishares Nasdaq Biotechnology

Ishares Nasdaq Biotechnology (0JGB)

LSE
106.38
0.00
(0.00%)
Closed 22 January 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
106.38
Bid
0.00
Offer
0.00
Volume
6,649
0.00 Day's Range 0.00
106.38 52 Week Range 106.38
Market Cap
5.915B
Previous Close
106.38
Open
-
Last Trade
5000
@
135.4
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,442
Shares Outstanding
55,600,000
Dividend Yield
-
PE Ratio
24.22
Earnings Per Share (EPS)
5.62
Revenue
52.52M
Net Profit
312.5M

About Ishares Nasdaq Biotechnology

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
www.ishares.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Ishares Nasdaq Biotechnology is listed in the Mgmt Invt Offices, Open-end sector of the London Stock Exchange with ticker 0JGB. The last closing price for Ishares Nasdaq Biotechno... was US$106.38. Over the last year, Ishares Nasdaq Biotechno... shares have traded in a share price range of US$ 106.38 to US$ 106.38.

Ishares Nasdaq Biotechno... currently has 55,600,000 shares in issue. The market capitalisation of Ishares Nasdaq Biotechno... is US$5.91 billion. Ishares Nasdaq Biotechno... has a price to earnings ratio (PE ratio) of 24.22.

Ask ADVFN Intelligence (AI)

0JGB Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100106.38106.38106.38138106.38DE
400106.38106.38106.3897106.38DE
1200106.38106.38106.382442106.38DE
2600106.38106.38106.381346106.38DE
5200106.38106.38106.381210106.38DE
15600106.38106.38106.38817106.38DE
26000106.38106.38106.381028106.38DE

0JGB - Frequently Asked Questions (FAQ)

What is the current Ishares Nasdaq Biotechno... share price?
The current share price of Ishares Nasdaq Biotechno... is US$ 106.38
How many Ishares Nasdaq Biotechno... shares are in issue?
Ishares Nasdaq Biotechno... has 55,600,000 shares in issue
What is the market cap of Ishares Nasdaq Biotechno...?
The market capitalisation of Ishares Nasdaq Biotechno... is USD 5.91B
What is the 1 year trading range for Ishares Nasdaq Biotechno... share price?
Ishares Nasdaq Biotechno... has traded in the range of US$ 106.38 to US$ 106.38 during the past year
What is the PE ratio of Ishares Nasdaq Biotechno...?
The price to earnings ratio of Ishares Nasdaq Biotechno... is 24.22
What is the cash to sales ratio of Ishares Nasdaq Biotechno...?
The cash to sales ratio of Ishares Nasdaq Biotechno... is 144.09
What is the reporting currency for Ishares Nasdaq Biotechno...?
Ishares Nasdaq Biotechno... reports financial results in USD
What is the latest annual turnover for Ishares Nasdaq Biotechno...?
The latest annual turnover of Ishares Nasdaq Biotechno... is USD 52.52M
What is the latest annual profit for Ishares Nasdaq Biotechno...?
The latest annual profit of Ishares Nasdaq Biotechno... is USD 312.5M
What is the registered address of Ishares Nasdaq Biotechno...?
The registered address for Ishares Nasdaq Biotechno... is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Ishares Nasdaq Biotechno... website address?
The website address for Ishares Nasdaq Biotechno... is www.ishares.com
Which industry sector does Ishares Nasdaq Biotechno... operate in?
Ishares Nasdaq Biotechno... operates in the MGMT INVT OFFICES, OPEN-END sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
BSFABsf Enterprise Plc
3.375p
(35.00%)
13.75M
STBSecure Trust Bank Plc
465.00p
(33.62%)
929.66k
TIATialis Essential It Plc
26.50p
(23.26%)
105.62k
CBGClose Brothers Group Plc
298.40p
(21.90%)
4.6M
NTQEnteq Technologies Plc
1.25p
(-23.31%)
3.22M
BANKFiinu Plc
8.625p
(-15.85%)
21.19M
TIRTiger Royalties And Investments Plc
0.135p
(-15.63%)
75.44M
RCGHRc365 Holding Plc
1.80p
(-14.29%)
1.7M
INDIIndus Gas Limited
7.80p
(-13.33%)
214.66k
NTVONativo Resources Plc
0.0021p
(0.00%)
2.71B
PREMPremier African Minerals Limited
0.026p
(-3.70%)
623.1M
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
TRPTower Resources Plc
0.0305p
(0.00%)
504.66M
SYMESupply@me Capital Plc
0.003p
(-3.23%)
469.16M

Discussion

View Full Feed
cjstocksup cjstocksup 3 minutes ago
2 posts below:
Barron wiped that smile from Biden’s face.

What do you think he said?
https://x.com/DefiantLs/status/1881528507479830626

🚨BREAKING: We obtained the unedited audio from Barron's shoutout! LISAN AL GAIB!
https://x.com/AutismCapi
skitahoe skitahoe 3 minutes ago
Gus, it all sounds great, and I wish it were that simple. I believe that we're already in the lead in doing this, but getting even close to curing most of the people with all sorts of cancer is still a long way off.

When I was in engineering school in the 1960's, two things were beli
NWBO
k9narc k9narc 4 minutes ago
Just soak your pasta in cold water, and finish it in the sauce.

YUM....
familyof5 familyof5 5 minutes ago
Sounds like you are insinuating NoMoDo's post are fabrications?


fab·ri·ca·tion
/?fabr?'kaSH?n/
noun
noun: fabrication; plural noun: fabrications

the action or process of manufacturing or inventing something.
"the assembly and
HMBL
Investor082 Investor082 5 minutes ago
Let me make it simple. Merck is not interested. If Merck was genuinely interested, they would have partnered and not run the risk of another competitor making an attractive offer.

LP is likely bending over backwards and yet no interest from any big pharma.
NWBO
Cassius Longinus Cassius Longinus 5 minutes ago
You are correct. It just all seemed so similar to the Innovation case. I should have read more carefully!
IPIX
bas2020 bas2020 6 minutes ago
You haven't seen the post-approval PRs yet, have you?
NWBO
band aid band aid 6 minutes ago
This company in 20 fffnnnn years has NEVER EVER MADE A CENT OF PROFIT. FACT. Thats why it trades at as close to zero pennys per million shares. Sickening. IMHO
BIEL
mascale mascale 8 minutes ago
So verifiable waterchaser zero-data-based reports and allegations continue--including waterchaser-post of apparently extensive Miro operations(?)!
HIRU
I-Glow I-Glow 8 minutes ago
The Debt was liquidated when Bioamber was liquidated.

Only the secured and non-secured creditors received anything and it was impaired.

Time for you to post something from 2014.

IG
Green Leaf Smoker Green Leaf Smoker 9 minutes ago
What a Phil..aster those going down in flames following Fraudster Fahman to bankruptcy by Gobler'ing this POS PLAL PHIL up to personnel bankruptcy....💩💩💩Lot of SELLERS were lining (💩ing) up today of PHIL @ O.OOO2 except few to no buyers at O.OOO3 of this pile of &#
PHIL
Genz2 Genz2 9 minutes ago
https://hackread.com/redline-vidar-raccoon-malware-stole-1-billion-passwords-2024/

Wave’s ‘better security at less than half the cost!’ should be the GO TO SOLUTION!!!...Wave MFA/VSC!!!
Investor082 Investor082 9 minutes ago
Problem is DCVAX platform has careful data collected over 15 years and yet no interest from BP.
Dangling another carrot?
NWBO
janice shell janice shell 9 minutes ago
Another reason to cook one's pasta properly. According to directions.
bas2020 bas2020 10 minutes ago
I saw the announcement and though interesting, it was very cursory regarding AI and its use in healthcare. They did say that a personalized cancer vaccine solution would be mRNA based, and we know the limitations of that technology.
NWBO
Susie924 Susie924 10 minutes ago
Dan Diamond
@ddiamond
·
55m
Trump officials have paused all external communications at health agencies like CDC, FDA, NIH.

No health alerts, updates to key websites, or MMWRs for now.

And no indication how long the pause will last.
cjstocksup cjstocksup 11 minutes ago
This is good, as I said yesterday, we would not have won without Elon Musk.

My talk today at the Presidential Parade

https://x.com/elonmusk/status/1881547272556777647
newmedman newmedman 11 minutes ago
That's an interesting article. I read something awhile back about Starlink that wasn't quite as favorable. Those satellites fly at such a low orbit that they are starting to clutter the sky for ground telescopes and the astronomy community isn't quite to happy about it.
Money hunt Money hunt 12 minutes ago
it’s big https://www.biospace.com/epigenetics-market-size-forested-to-be-worth-over-usd-61-04-bn-by-2033
FOXO
Turbomunkey Turbomunkey 12 minutes ago
Tiktok app likely to remain unlisted on app stores, in accordance with the new law.

https://www.google.com/amp/s/wccftech.com/tiktok-might-never-appear-on-apple-app-store-except-for-one-condition/amp/
ILLR
evenpar evenpar 13 minutes ago
style="font-size: 16px"https://youtu.be/iTsCFW8yqH4?si=bBr4MiSKbgZ1CbqQ....
It's a yr old , but this why we are all here.
FNMA
955 955 14 minutes ago
He (Bessent) acknowledges the necessity of working with Congress for any structural changes to the GSEs, such as providing an explicit government guarantee or regulating returns to investors https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175697134

Your Recent History

LSE
0JGB
Ishares Nasdaq Biotechno...
BOV
PMSP11BL
Prefeitura Municipal Sao...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads